Skip to main content
. 2019 May 8;9(1 Suppl):8S–14S. doi: 10.1177/2192568219828729

Table 4.

Nonneurological Adverse Events.

Nonneurological Adverse Events n % (95% CI)
Any of the nonneurological adverse events specified below 184 67.6 (61.7-73.2)
  Stroke 0 0.0 (0.0-1.3)
  Cardiac arrest 1 0.4 (0.0-2.0)
  Surgery related 108 39.7 (33.8-45.8)
  Cerebrospinal fluid leak 2 0.7 (0.1-2.6)
  Dural tear 43 15.8 (11.7-20.7)
  Screw malposition 7 2.6 (1.0-5.2)
  Loss of correction 18 6.6 (4.0-10.3)
  Implant failure 40 14.7 (10.7-19.5)
  Pedicle fracture 1 0.4 (0.0-2.0)
  Laminar fracture 0 0.0 (0.0-1.3)
  Visceral injury 6 2.2 (0.8-4.7)
  Vascular injury 1 0.4 (0.0-2.0)
  Excessive bleeding 14 5.1 (2.8-8.5)
  Graft dislodgement 1 0.4 (0.0-2.0)
  Graft donor site pain 1 0.4 (0.0-2.0)
  Intraoperative coagulopathy 3 1.1 (0.2-3.2)
  Visual field deficits/loss 0 0.0 (0.0-1.3)
  Malignant hyperthermia 0 0.0 (0.0-1.3)
  Anesthetic complication 4 1.5 (0.4-3.7)
  Wound infection 26 9.6 (6.3-13.7)
  Deep infection 12 4.4 (2.3-7.6)
  Superficial infection 8 2.9 (1.3-5.7)
  Graft site infection 2 0.7 (0.1-2.6)
  Wound dehiscence/Stitch abscess 7 2.6 (1.0-5.2)
  Gastrointestinal 11 4.0 (2.0-7.1)
  Superior mesenteric artery syndrome 0 0.0 (0.0-1.3)
  Ileus 11 4.0 (2.0-7.1)
  Deep vein thrombosis 8 2.9 (1.3-5.7)
  Pulmonary embolism 3 1.1 (0.2-3.2)
  Respiratory 14 5.1 (2.8-8.5)
  Pneumonia 10 3.7 (1.8-6.7)
  Atelectasis 6 2.2 (0.8-4.7)
  Urogenital 37 13.6 (9.8-18.3)
  Urinary retention 10 3.7 (1.8-6.7)
  Retrograde ejaculation 0 0.0 (0.0-1.3)
  Urinary tract infection 30 11.0 (7.6-15.4)
  Other 119 43.8 (37.8-49.9)